Novartis Investigative Site

Gwangju Gwangyeoksi, Gwangju 61748

0 studies enrolling now · 1 studies all time

What they study most

Systemic Lupus Erythematosus

Studies at this site

• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling